Search Results
PF-06463922 10mg 10mg | Purity Not Available
Adooq Bioscience
LCZ696 5mg 5mg | Purity Not Available
Adooq Bioscience
LCZ696 is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for hypertension and heart failure.
More Information Supplier PageLCZ696 25mg 25mg | Purity Not Available
Adooq Bioscience
LCZ696 is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for hypertension and heart failure.
More Information Supplier PageLCZ696 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
LCZ696 is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for hypertension and heart failure.
More Information Supplier PageLCZ696 10mg 10mg | Purity Not Available
Adooq Bioscience
LCZ696 is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for hypertension and heart failure.
More Information Supplier PageGSK-2193874 50mg 50mg | Purity Not Available
Adooq Bioscience
GSK2193874 was identified as a selective, orally active TRPV4 blocker that inhibits Ca(2+) influx through recombinant TRPV4 channels and native endothelial TRPV4 currents.
More Information Supplier PageGSK-2193874 25mg 25mg | Purity Not Available
Adooq Bioscience
GSK2193874 was identified as a selective, orally active TRPV4 blocker that inhibits Ca(2+) influx through recombinant TRPV4 channels and native endothelial TRPV4 currents.
More Information Supplier PageGSK-2193874 10mg 10mg | Purity Not Available
Adooq Bioscience
GSK2193874 was identified as a selective, orally active TRPV4 blocker that inhibits Ca(2+) influx through recombinant TRPV4 channels and native endothelial TRPV4 currents.
More Information Supplier Page